174 related articles for article (PubMed ID: 28771676)
1. Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.
Kanate AS; DiGilio A; Ahn KW; Al Malki M; Jacobsen E; Steinberg A; Hamerschlak N; Kharfan-Dabaja M; Salit R; Ball E; Bashir Q; Cashen A; Couriel D; Diez-Martin J; Katsanis E; Linhares Y; Mori S; Nash R; Pawarode A; Perales MA; Phipps CD; Richman C; Savani BN; Shapira MY; Stiff P; Strair R; Fenske TS; Smith SM; Sureda A; Olteanu H; Hamadani M
Br J Haematol; 2018 Sep; 182(6):916-920. PubMed ID: 28771676
[No Abstract] [Full Text] [Related]
2. Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center.
Wang J; Wei L; Ye J; Yang L; Li X; Cong J; Yao N; Cui X; Wu Y; Ding J; Zhang L
Int J Hematol; 2018 Jan; 107(1):98-104. PubMed ID: 28856590
[TBL] [Abstract][Full Text] [Related]
3. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
[TBL] [Abstract][Full Text] [Related]
4. Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T-Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Philippe Walter L; Couronné L; Jais JP; Nguyen PD; Blaise D; Pigneux A; Socié G; Thieblemont C; Bachy E; Fegueux N; Chevallier P; Mohty M; Yakoub-Agha I; Peffault de Latour R; Jaccard A; Hermine O;
Am J Hematol; 2021 Jul; 96(7):834-845. PubMed ID: 33864708
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin Lymphoma.
Maeng CH; Ko YH; Lim DH; Kang ES; Choi JY; Kim WS; Kim SJ
Cancer Res Treat; 2017 Jan; 49(1):92-103. PubMed ID: 27188204
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of extranodal NK-T cell lymphoma-nasal type].
Wang H; Li XJ; Zhang SW; Xi Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Nov; 40(11):850-4. PubMed ID: 16408753
[TBL] [Abstract][Full Text] [Related]
7. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
[TBL] [Abstract][Full Text] [Related]
8. Donor lymphocyte infusion for extranodal NK/T cell lymphoma, nasal type, relapsed after allogeneic hematopoietic SCT.
Ito T; Makishima H; Nakazawa H; Senoo Y; Senoo N; Ishida F
Bone Marrow Transplant; 2011 Sep; 46(9):1270-1. PubMed ID: 21057552
[No Abstract] [Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type.
Ennishi D; Maeda Y; Fujii N; Kondo E; Shinagawa K; Ikeda K; Ichimura K; Yoshino T; Tanimoto M
Leuk Lymphoma; 2011 Jul; 52(7):1255-61. PubMed ID: 21599584
[TBL] [Abstract][Full Text] [Related]
10. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.
Liang R
Br J Haematol; 2009 Oct; 147(1):13-21. PubMed ID: 19604234
[TBL] [Abstract][Full Text] [Related]
11. Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Michot JM; Mazeron R; Danu A; Lazarovici J; Ghez D; Antosikova A; Willekens C; Chamseddine AN; Minard V; Dartigues P; Bosq J; Carde P; Koscielny S; De Botton S; Ferme C; Girinsky T; Ribrag V
Eur J Cancer; 2015 Nov; 51(16):2386-95. PubMed ID: 26254810
[TBL] [Abstract][Full Text] [Related]
12. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
[TBL] [Abstract][Full Text] [Related]
13. Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma.
Nie M; Bi XW; Zhang WW; Sun P; Xia Y; Liu PP; Huang HQ; Jiang WQ; Li ZM
Sci Rep; 2016 Apr; 6():23996. PubMed ID: 27041507
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation.
Jeong SH; Song HN; Park JS; Yang DH; Koh Y; Yoon SS; Lee HW; Eom HS; Won JH; Kim WS; Kim SJ
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2471-2478. PubMed ID: 30064012
[TBL] [Abstract][Full Text] [Related]
16. CD30-positive cutaneous extranodal natural killer/T-cell lymphoma: clinicopathological features and survival outcomes.
Lee WJ; Moon IJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
Int J Dermatol; 2019 Jun; 58(6):688-696. PubMed ID: 30597548
[TBL] [Abstract][Full Text] [Related]
17. Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China.
Liang R; Wang Z; Bai QX; Gao GX; Yang L; Zhang T; Gu HT; Dong BX; Shu MM; Hao CX; Zhang N; Chen XQ
Oncol Res Treat; 2016; 39(1-2):45-52. PubMed ID: 26891121
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
Jia J; Song Y; Lin N; Liu W; Ping L; Zheng W; Wang X; Xie Y; Tu M; Zhang C; Ying Z; Deng L; Ding N; Zhu J
Ann Hematol; 2016 Dec; 95(12):2023-2031. PubMed ID: 27595760
[TBL] [Abstract][Full Text] [Related]
19. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
Yokoyama H; Yamamoto J; Tohmiya Y; Yamada MF; Ohguchi H; Ohnishi Y; Okitsu Y; Fukuhara N; Ohba-Ohtsuka R; Kohata K; Ishizawa K; Kameoka J; Harigae H
Leuk Lymphoma; 2010 Aug; 51(8):1509-12. PubMed ID: 20496989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
